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Abstract 
 
Biofilm formation has been demonstrated for several pathogens and is evidently a 
significant microbial survival strategy. They have immense clinical relevance for 
their role in various infectious diseases and a range of device-related infections 
because of their increased tolerance to antibiotics. Intra- and inter-species 
interactions play an important role in the population dynamics and distribution of species 
within the biofilm community, thereby altering the course of infections and response 
to antimicrobial therapy. For instance, P. aeruginosa in the cystic fibrosis airway 
produces an exoproduct, 4-Hydroxy-2-heptylquinoline N-oxide (HQNO), that 
causes wild-type cells of S. aureus to phenotypically switch to small colony variants 
(SCVs). SCVs are problematic in chronic infections; even though they comprise a 
minor proportion of the population, they persist by virtue of their inherent resilience 
and host adaptability. 
A comprehensive 3-D computational cellular automaton model of biofilm dynamics was 
developed to investigate the role of SCVs in the antibiotic tolerance of polymicrobial 
biofilms. This model integrates the following processes: nutrient transport and utilization, 
biomass growth, division, death and detachment, quorum sensing, phenotypic switching, 
EPS production, and antimicrobial therapy. Biofilm growth dynamics were explored for two 
cases: (i) in the absence and (ii) presence of SCVs. A single growth-limiting nutrient was 
taken into consideration whose concentration was taken to be 4 g/m3. To inspect the 
recalcitrance in response to antibiotic-dependent killing, the biofilm was subjected to a 
range of antibiotic concentrations (7, 9, 11, 13, 15 g/m3). The antimicrobial treatment was 
initiated 12 hours prior to the maxima of P. aerginosa (slower-growing species) population 
dynamics curve and was continued for 12 hours. The model predicted the following 
features: treating a biofilm with antibiotic concentration less than a specific threshold 
extends its lifetime, external stress can influence interspecific competition, production of 
SCVs is potentiated in response to antibiotic treatment, and stratified patterns of survival. 
These studies will possibly give some insight and provide data for the refinement of 
existing treatment strategies and/or to develop novel effective therapies for biofilm 
infections.
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Nomenclature 
µmax  Maximum specific growth rate 
m  Maintenance coefficient 
YBN  Yield of biomass from nutrient 
YEN  Yield of EPS from nutrient 
YHQNO  Yield of HQNO from nutrient 
CN,bulk  Bulk nutrient concentration 
CAb,bulk  Bulk antibiotic concentration 
Di  Diffusivity of component ‘i’ in biofilm 
Di,aq  Diffusion rate of ‘i’ in aqueous phase 
Di,e/Di,aq Relative effective diffusivity 
Ki  Half-saturation coefficient 
v  Local fluid velocity 
α  Conversion rate for up-regulation (QS) 
β  Spontaneous down-regulation rate (QS) 
γ  Transition constant (QS) 
α'  Conversion rate for SCV-switching (PS) 
β'  Spontaneous WT-switching rate (PS) 
γ'  Transition constant (PS) 
rA,u  Autoinducer production rate by up-regulated cells 
rA,d  Autoinducer production rate by down-regulated cells 
rHQNO,u  HQNO production rate by up-regulated cells 
rHQNO,d  HQNO production rate by down-regulated cells 
KB,max  Maximum specific reaction rate of anitibiotic with respect to biomass 
KE,max  Maximum specific reaction rate of anitibiotic with respect to EPS 
mOneCell Mass of one cell 
COneCell  Concentration of one cell 
CBIC  Bacterial inhibitory concentration 
Cmax  Concentration corresponding to maximum consumption rate 
Δt  Time step used for CA 
Δx  Element size
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Chapter 1 
 
Introduction 
   
 
1.1 Overview 
Antonie van Leeuwenhoek, who discovered microbial attachment to his own tooth surface, 
is credited with the discovery of biofilm. But the theory describing the process was not 
developed until 1978 [1]. A biofilm is any aggregate of microorganisms in 
which cells adhere to each other and/or to a surface. They may form on solid surfaces 
(living or non-living) in contact with moisture or at air-fluid interfaces and can be prevalent 
in natural, industrial and hospital settings [2][3]. These cells are quite often embedded in a 
self-produced matrix of extracellular polymeric substances, EPS, which are high-molecular 
weight compounds (generally composed of proteins, extracellular DNA, polysaccharides, 
etc) secreted by microorganisms into their environment. They acts as “intercellular cement” 
[4], establishing the functional & structural integrity of biofilms. They constitute 50-90% of 
a biofilm's total organic matter [5-7].  
1.1.1 Biofilm vs. Planktonic Organisms  
Microbial cells in a biofilm are physiologically distinct from their planktonic counterparts 
by reduced growth rate, up- and/or down- regulation of certain operating genes, etc.[6] 
Estimates vary, but it has been suggested by some that as much as 40% of the genes of a 
bacterium may undergo up- or down- regulation in the transition from planktonic to biofilm 
state [2,8,9]. So, even though genetically they are the same, expression of some of the genes 
has undergone a dramatic shift and it is almost as if the two states (planktonic and biofilm) 
were entirely different organisms. 
Growth within biofilms offers protection from a wide variety of environmental challenges 
like acidic pH, metal toxicity, antibiotics etc [2] and shields against host immune responses 
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(even though phagocytes penetrate biofilms via fluid-filled channels, they fail to access 
bacteria encased within the EPS matrix) [10]. 
1.1.2 Clinical Relevance of Biofilms 
Infectious processes in which biofilms play a role include catheter infections, urinary tract 
infections, middle-ear infections, formation of dental plaque, endocarditis, bacterial 
vaginosis, coating contact lenses, infections in cystic fibrosis, infections of permanent 
indwelling devices such as joint prostheses and heart valves etc. 
Despite the sophistication, microbial infections can develop on all medical devices and 
tissue engineering constructs. 60-70% of hospital acquired infections are associated with the 
implantation of a biomedical device [11]. 
1.1.3 Antibiotic Tolerance of Biofilms 
It is often said that new antibiotics are needed to combat drug-resistant pathogens. But we, 
in fact, never had antibiotics capable of eliminating an infection completely; therefore this is 
only a part of the requirement [12]. 
The antimicrobial drugs that are traditionally developed are designed and tested to eradicate 
planktonic bacteria under the assumption that they would kill the same bacteria wherever 
they are found. However, we now know that, planktonic bacteria are more susceptible to 
those agents when compared to their biofilm brethren. Also, it has been found that biofilms 
are involved in a number of microbial infections in the body, by one estimate 80% of all 
infections [13]. Thus, we can begin to understand why antibiotics don't work well enough 
against infections, especially those caused by biofilms. 
1.2 Present Day Scenario 
1.2.1 Current Understanding of Controlling Factors 
Microbial biofilms are thought to employ spatial organization and physiological cooperation 
to potentiate their metabolic efficiency and their resistance/tolerance to changes in their 
local environment [14]. The current understanding is that biofilms, in response to varying 
environmental conditions, can adopt different structures, which can range from 
homogeneous monolayers to heterogeneous structures including mushrooms and filaments 
[15]. A range of factors have been suggested to influence biofilm structure, including cell 
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death [16], hydrodynamic shear [17-19], mass transport [20,21], adhesion[22], cell motility 
[23], and detachment [24].  
Biofilms can be formed by a single bacterial strain and most biofilm studies examine such 
cultures. However, majority of the naturally occurring biofilms are actually formed by 
multiple bacterial species [25] and understanding of the molecular mechanisms involved in 
the intercellular interactions within such biofilms is limited. Numerous studies have 
evaluated the susceptibility of multi-species vs. mono-species biofilms against antibiotic, 
and in most cases, polymicrobial biofilm was notably more resistant [26-30]. 
1.2.2 Computational Modeling 
A computational approach that has revolutionized biofilm modeling is cellular automata 
(CA) [31,32]. CA are discrete models, in which space, time, and properties of the system 
can only have a finite number of possible states [33]. To date, the relative contributions of 
the parameters mentioned in section 1.2.1 have not been elucidated. Furthermore, previous 
work investigating the effect of cell death on biofilm development had considered 2-D 
systems [33]. Another study investigated the protection from antibiotic killing in biofilms 
based on a mechanism of localized nutrient limitation and slow growth; however the 
computational model used for it was one-dimensional [34]. Hence, the data obtained from 
these studies may not be physiologically relevant.  
1.3 Motivation 
Computer models of biofilm dynamics are valuable tools in exploring the formation of 
biofilms. Models can be used to test hypotheses or make predictions about how specific 
processes influence the biofilm structure or function. Often there are multiple mechanisms 
that are difficult to distinguish experimentally and in such cases theoretical investigations 
are particularly appealing.  
To date, biofilm models used to explore the degrees of recalcitrance to killing by 
antimicrobials that take account of inter-species interactions are limited. The species present 
and the interactions between them critically influence the development and shape of the 
community. Understanding these mechanisms will aid in the development of techniques for 
combating bacterial biofilms in clinical areas. 
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One possible mechanism which explains the antibiotic tolerance of biofilms and depends on 
the inter-species interaction is the emergence of small colony variants (SCVs). Although 
SCVs have been known to exist for over a century, little attention was given to them 
originally as they were believed to be non-virulent and hence clinically insignificant. 
However, as their role in persistent infections began to unravel, it became crucial to 
thoroughly explore the mechanisms of SCV persistence and tolerance. 
Thus, there was a need to develop a comprehensive 3-D computational CA model for 
polymicrobial biofilm growth which would include cell growth, cell division, cell death, 
attachment and detachment of cell, EPS production, cell-signaling process, and 
antimicrobial therapy. A detailed understanding of spatio-temporal variation in biofilm 
structures may lead to the development of novel therapeutics, and other potential 
biotechnological applications via the formation of synthetic biofilms. The identification of 
potential targets for inhibition of biofilm development may ultimately provide the means to 
diminish the impact of polymicrobial diseases on human health. 
1.4 Objective 
Specific Aim 1:  
(a) To incorporate the ability to resume simulations by reading data from files. 
This enables one to resume simulations from a specific time point with the existing 
circumstances or begin an antibiotic treatment. Thus the effect of adding antibiotic 
at different concentrations could be seen for the same biofilm morphology. 
(b) To add a cell ID number to every cell that is generated so that the location of 
individual cells can be tracked within the biofilm. 
(c) To make the code more efficient (by reducing the space and time complexity of the 
algorithm) and eliminate any redundancy in the code.  
Specific Aim 2:  
(a) To make the code specific to a cystic fibrosis by incorporating species interactions 
of S. aureus and P. aeruginosa involved in the disease. 
(b) To investigate how the cell-cell interactions (like competition, cooperation), 
presence of SCVs, environmental heterogeneity etc. play a role in the antibiotic 
tolerance of biofilms. 
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Chapter 2 
 
Literature Review 
   
 
2.1 Introduction to Biofilm Development 
Biofilms are omnipresent. Almost all species of microorganisms, not merely bacteria, have 
mechanisms by which they can adhere to surfaces and to each other. Biofilms form on 
nearly every non-shedding surface in contact with moisture or at air-fluid interfaces. 
Depending on the environmental conditions, they can be as thin as a few cell layers or many 
inches thick. There are five stages of biofilm formation: (i) Conditioning film; initial 
attachment, (ii) Adsorption and irreversible attachment, (iii) Growth and colonization (iv) 
EPS production; biofilm formation, (v) Dispersion. It has been shown that when biofilm is 
being created, the pathogens inside it can communicate with each other to coordinate gene 
expression according to the density of their local population. This bacterial communication 
system to coordinate behaviors at the population level is known as quorum sensing.  
2.1.1 Formation of Biofilms 
Development of a biofilm begins with the conditioning films altering the surface properties 
of the substratum and allowing microbes to adhere to the surface. For instance, when sterile 
medical implants are exposed to bodily fluids, proteins, polysaccharides, ions and various 
other components adhere to the surface and form a conditioning film which “attracts” 
microorganisms that would otherwise be unable to attach to the original surface [35]. The 
colonizers initially use weak, reversible adhesion via van der Waals forces to adhere to the 
surface. If they are not removed straight away, they can fasten themselves more 
permanently using cell adhesion structures such as pili. In the next step, production of EPS 
anchors the bacteria to the surface allowing colonies to grow. A fully developed biofilm 
contains an EPS matrix and vertical structures separated by interstitial spaces where the 
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fluid channels provide hydration while removing wastes from different regions of the 
biofilm. The final stage of biofilm formation is known as dispersion, and is the stage in 
which the biofilm is established and may only change in shape and size. 
2.1.2 Quorum Sensing (QS) 
Bacterial species that use quorum sensing, constitutively produce and release 
certain signaling molecules called autoinducers. They also have a receptor that can 
specifically detect these signaling molecules. But the odds of a bacterium detecting its own 
secreted autoinducer are pretty slim. Moreover, when only a few bacterial cells are in close 
proximity, diffusion reduces the concentration of autoinducer in the surrounding medium to 
negligible amounts. However, as the population grows, the autoinducer concentration passes 
a certain threshold, and the receptor becomes fully activated thereby inducing the up-
regulation of specific genes, causing all of the cells to begin transcription at approximately 
the same time. 
As a result, regulation by QS would allow the cells to save their resources under low density 
conditions by expressing appropriate behavior only when it is effectual. This coordinated 
behavior of bacterial cells at the population level is useful in a variety of situations like 
biofilm formation [36,37], virulence [36,37], symbiosis [36], competence [36], antibiotic 
production [36], motility [36], etc. Studies have shown that this cell-cell communication via 
autoinducers can be both intra- and inter-species as well [36,37]. 
2.2 Polymicrobial Biofilm 
Biofilms can be formed by a single bacterial strain and most biofilm studies examine such 
cultures. However, majority of natural biofilms are actually produced by multiple bacterial 
species. Numerous studies have evaluated the susceptibility of multi-species vs. mono-
species biofilms against antibiotic, and in most cases, the former was notably more resistant 
[30-34]. The species that constitute a polymicrobial biofilm and the interactions between 
them (synergistic or antagonistic) critically influence the development and shape of the 
community[38]. Understanding these mechanisms will aid in the development of techniques 
for combating bacterial biofilms in clinical areas. 
The interactions between different species within a biofilm could be cooperative or 
competitive. One possible cooperative interaction is where one member provides conditions 
that promote survival of other members [38]. For instance, when anaerobic bacteria are 
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grown along with aerobic bacteria in a mixed biofilm, the aerobic bacteria at the top, 
consume oxygen thereby providing anaerobic conditions within the deeper layers of the 
biofilm in which anaerobic bacteria can multiply [39]. Thus, in this case, even though 
anaerobic bacteria are sensitive to oxygen, they can survive and persist under aerobic 
conditions [40,41]. One possible competitive interaction is where one species actively 
inhibits the growth of others, by producing inhibitory compounds or consuming essential 
nutrients [38]. For example, a marine bacterium Pseudoalteromonas tunicate hinders the 
growth of other marine bacteria isolated from the same environment by producing an 
antibacterial protein (AlpP) [42]. These interactions are important factors in determining the 
architecture of the polymicrobial biofilm community. 
2.3 Proposed Mechanisms for Antibiotic Tolerance in Biofilms 
The four primary theories explaining the reduced susceptibility of biofilms are: (i) Physical 
or chemical diffusion barriers to antibiotic penetration into the biofilm; the charge of 
polymers [43] and antibiotic-degrading enzymes [44] in the matrix may lead to binding 
and/or deactivation. (ii) Altered microenvironment and slow growth; most antimicrobials 
are effective in killing actively growing cells and nutrient concentration gradients within 
biofilms lead to gradients in microbial growth rate and activity. (iii) Activation of general 
stress response; for example: drug efflux pumps (they pump out unwanted toxic substances 
via an energy-dependent mechanism). Antibiotics can act as inducers and regulators of 
the expression of some efflux pumps [45] which may confer resistance to a wide range of 
antimicrobials. (iv) Emergence of biofilm-specific phenotype; a small subpopulation of 
microorganisms in a biofilm adopt a highly protected phenotypic state. These are dormant 
cells and are highly tolerant to killing by antibiotics. Example: persisters, small colony 
variants (SCVs). The dormancy of persisters can be observed by a typical biphasic antibiotic 
killing pattern with rapid killing of bulk population in the initial stages, followed by a 
plateau where only the persister subpopulation remains alive or are slowly killed. This 
biphasic pattern is observed both with increasing antibiotic concentration and with 
increasing treatment time [46]. 
2.4 Small Colony Variants (SCVs) 
Small colony variants (SCVs) are a slow-growing phenotype that are part of the normal life 
cycle of bacteria, and often arise in response to environmental stresses, such as antibiotic 
treatment, starvation, host cationic peptides [47]. They are characteristically slow growing 
8 
and therefore constitute a small fraction of the population from which they arise but 
continue to persist because of their inherent resilience and host adaptability [48].  
Apart from slow growth rate (in the case of S. aureus, SCVs divide at about one-ninth the 
rate of wild-type cells [49]), typical characteristics of SCVs include atypical colony 
morphology, lack of pigmentation, reduced hemolytic activity, reduced coagulase activity, 
reduced carbohydrate utilization, low virulence potential [49-51], reduced colony size 
(nearly one-tenth the size of the colonies associated with wild-type bacteria) [49], increased 
resistance to aminoglycosides (susceptibility of SCVs to aminoglycosides was one-
tenth to one-thirtieth that of the parent strain) [49], diminished electron transport 
(observed in various species of Staphylococcus, Enterococcus, and Pseudomonas) [48], 
higher tendency for adhesion (express more surface adhesins compared to wild-type) to 
biotic or abiotic surfaces with enhanced intracellular persistence [52,53], increased 
biofilm-forming capacity in comparison with the wild-type parent [54]. They are capable of 
reversion to a wild-type or wild-type-like variant; thereby constituting a highly dynamic 
subpopulation serving as a reservoir for recurrent infections as illustrated in Fig. 2.1 [48]. 
Thus, phenotype switching enables bacteria to hide inside the host cell without inducing a 
strong host immune response. 
 
Figure 2.1: A schematic of a recurring biofilm infection. Untreated biofilms of bacteria often 
consist of WT (major population) and SCV (minor population). The WT population diminishes 
and SCVs survive under environmental stress, such as antibiotic treatment in turn making 
SCVs the dominant members of the population. However, when the selective pressure is 
removed, a proportion of SCVs revert to either the WT phenotype or a WT-like phenotype 
thereby regaining characteristics that enable faster growth. The WT organisms then proliferate 
and once again become the dominant members of the population. 
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SCVs are a challenging aspect in chronic infections such as cystic fibrosis in lung, chronic 
obstructive pulmonary disease, osteomyelitis, diabetic foot ulcers, chronic wound infections, 
etc., where antimicrobials are administered during the acute phase of infection but fail to 
eradicate SCVs, which remain dormant within the host and later cause recurring infection. 
The occurrence of SCVs has been observed to be the highest in cystic fibrosis and 
osteomyelitis [49]. SCVs of S. aureus were identified in 24% of patients suffering with 
cystic fibrosis [55]. 
2.5 Cystic Fibrosis: Interaction Between S. aureus and P. aeruginosa 
Cystic fibrosis (CF) is a genetic disorder that mostly affects the lungs but could also affect 
pancreas, liver, kidneys, and intestine [56,57]. From an early age, the lungs of individuals 
with cystic fibrosis are colonized and infected by bacteria which thrive in the altered mucus 
that collects in the small airways of the lungs and lead to the formation of biofilms. Two of 
the most common pathogens found in CF lungs are S. aureus and P. aeruginosa. 
P. aeruginosa secretes an exoproduct, 4-hydroxy-2-heptylquinoline-N-oxide (HQNO), that 
suppresses the growth of many Gram-positive bacteria [58-60]. In the case of S. aureus, 
HQNO activates alternative sigma factor B, which alters the expression of several virulence 
factors, including those that regulate the ability to adhere, invade, and persist within host 
cells, and facilitates the emergence of SCV phenotype [61]. Since the biosynthesis of 
HQNO is up-regulated by the cell density-dependent quorum sensing mechanism [62], 
HQNO production would be expected to be amplified in biofilms, thus increasing the 
selection pressure for S. aureus SCVs. 
Both HQNO and SCVs of S. aureus were found in CF lungs, indicating that evolution of 
these variants does indeed occur within the human host [38]. It has been suggested that the 
formation of SCVs is a survival strategy adopted by S. aureus to withstand competition with 
P. aeruginosa [63]. In any case, this example highlights the assertion that interactions 
between species within biofilms must be taken into account when designing therapies. 
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Chapter 3 
 
Methodology 
   
 
A cellular automaton is a collection of cells on a grid of a specified shape. It evolves 
through a number of discrete time steps according to a set of rules (generally, some 
mathematical functions) that determine the new state of each cell (in the next time step) 
based on the current state of the cell and the states of its neighboring cells.  The rules are 
applied iteratively for as many time steps as desired. 
In the case presented here, an individual based cellular automaton was used in order to 
represent the growth and development of a bacterial biofilm on a surface in an aqueous 
environment. A useful feature associated with this kind of model is that each agent 
(bacterial cell) is treated as an individual, independent entity with its own state and 
behavior. To simulate behavioral variability, parameter values (Table 3.1) for each cell were 
randomly assigned within a range of ±10% of the mean values taken from literature. This 
feature is particularly useful for studying complex systems where individual heterogeneity is 
important, like in the case of biofilms. 
3.1 Simulation Domain 
For the biofilm domain, a cuboid of dimensions Lx x Ly x Lz was considered which was 
spatially discretized into cubical elements with edge length as 3 μm (refer Fig. 3.1). This 
elemental volume is suitable to harbor one bacterial cell and its extracellular constituents. 
Each of the elements is occupied by either a bacterium or an equivalent volume of liquid. 
The bottom surface (dimension: 120μm x 120μm) represented the substratum upon which 
the biofilm was allowed to develop. A continuously replenished nutrient reservoir was 
placed at the top at a distance of 18 μm from the substratum. The interface between the 
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nutrient reservoir and the biofilm domain is termed as the mass transfer boundary layer 
(MTBL).  
 
Figure 3.1: A schematic of the modeling domain 
Following boundary conditions were applied to the system: 
I. Periodic boundary conditions had been assumed in the x- and z- directions. Thus the 
modelling domain represents a curved surface where biofilm biomass at one edge 
wraps around to the other edge i.e. the element next to the cell with x- (or z-) 
coordinate as xmax (or zmax), in the positive x- (or z-) direction, would have its x- (or 
z-) coordinate as x = 0 (or z = 0) and the element after would have its x- (or z-) 
coordinate as x = 1 (or z = 1) and so on. This was done so as to avoid edge effects 
and to maintain continuity of the biofilm biomass. Thus, a large system was 
approximated by using a small domain. 
II. An ideal planar (120μm x 120μm) source of nutrient was placed just above ymax 
(taken as the combined height of the biofilm as well as MTBL). Dirichlet boundary 
condition (fixed boundary condition) was imposed for all grid elements at the 
boundary of the nutrient reservoir i.e. at y = ymax, concentration of the nutrient was 
taken as the bulk concentration. Moreover, MTBL is always situated at a fixed 
distance above the top of the biofilm and so the source of nutrient will move 
upwards, i.e. ymax changes, as the biofilm grows with time. 
III. Neumann boundary condition was applied at the substratum (boundary at the 
bottom of the domain) viz. at y = 0, concentration gradient is zero which then 
implies that the nutrient concentration at y = -1 (required for calculating 
concentrations at y = 0 using finite difference method) will be same as the nutrient 
concentration at y = 1. 
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3.2 Nutrient Transport and Uptake 
The nutrient concentration in the biofilm compartment depends on the balance between rate 
of nutrient transport due to diffusion and convection, and nutrient uptake rate by the 
bacterial cells. 
This phenomenon was modeled within each element of the simulation domain by using a 
discretized form of the three-dimensional convection-diffusion equation: 
 
Here, rN is the volumetric rate of nutrient consumption. CN and CB represent nutrient and 
biomass concentration at each discretized element (x,y,z) and at each time point, t, 
respectively. DN is the diffusivity of nutrient in the biofilm, which is determined by 
multiplying the diffusion rate in the aqueous phase (DN,aq) with the relative effective 
diffusivity DN,e/DN,aq, v is the local fluid velocity. 
Cells consume nutrient from the external environment and channel it into different 
metabolic pathways. Some nutrient may be directed into growth and product synthesis; 
another fraction is used to generate energy for maintenance activities. In the absence of 
product formation, it is assumed that all nutrient entering the cell is used for growth and 
maintenance functions. A complete account of nutrient uptake should include a maintenance 
component. The specific rate of nutrient uptake for maintenance activities is known as the 
maintenance coefficient.  
Biomass growth rate is dependent on the availability of nutrients and so it is influenced by 
the spatial distribution of nutrient concentration within the biofilm. In turn, bacterial growth, 
division, death, detachment etc. affects nutrient concentration fields. Thus the temporal and 
spatial distribution of nutrient concentration (CN) is intimately dependent on the local 
biomass concentration (CB). And so the nutrient consumption rate was assumed to be a 
function of both CB and CN, as stated below: 
 
13 
Here, µmax is the maximum specific growth rate, YBN is the yield of biomass from nutrient 
(yield coefficient), m is the maintenance coefficient and KN is the nutrient constant (half- 
saturation coefficient). µmax and KN are intrinsic parameters of the cell-nutrient system. 
3.3 Spatial and Temporal Evolution of Cellular Biomass 
3.3.1  Growth 
As it was mentioned earlier in section 3.2, inside the cell, the nutrient that has been 
consumed was utilized for two purposes: cell growth and endogenous metabolism. The 
endogenous metabolism was assumed to be proportional to the concentration of biomass, 
i.e. it is given by mCB. The nutrient that had not been consumed for endogenous metabolism 
was used for cell growth at an efficiency, YBN. 
 
3.3.2 Division 
As the bacterial cells consume nutrient, they keep on growing (biomass concentration 
increases) within their grid location. When the biomass of a bacterium reaches twice its 
native value, it divides into two daughter cells (refer Fig. 3.2(a)); each having a new set of 
parameters. One of the two daughter cells remains in the original location of the mother cell, 
whereas the other one is placed in a neighboring element in the direction that offers least 
mechanical resistance. 
 
(a) 
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2nd shell
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Mother cell
 
Figure 3.2: (a) A mother cell undergoing division, (b) Two-dimensional view of the 
neighbouring elements at increasing distances from the dividing cell 
During division, each direction is checked for free spaces at increasing distances from the 
mother cell, and the first direction in which such a free space is found is considered to be the 
direction of least mechanical resistance. For example, consider a mother cell that is 
undergoing division. At first, the immediate neighboring elements i.e. the 1st shell (33-13 = 
26 elements) as shown in Fig. 3.2 (b), will be checked for free spaces. If all of them are 
occupied, then the 2nd shell (53-33 = 98 elements) is checked and so on. Once an empty grid 
location is found, the entire line of cells between the mother cell and the closest free space is 
pushed away from the former by one element in the same line of direction so as to make 
space near the dividing cell where the second daughter cell is finally placed. 
If two or more directions with equal mechanical resistance (i.e. directions having empty 
positions at equal distances from the mother cell location) are found, one of those is chosen 
at random. 
3.3.3 Death 
In the 3-D computational model that has been developed, there are three possible 
mechanisms by which a cell can die: (i) the cell has been in stationary phase for a pre-
determined number of hours (tSP,limit), or (ii) the ratio of nutrient consumption to endogenous 
metabolism (R) falls below a certain threshold, or (iii) due to antibiotic treatment. 
If the ratio, R (=  rN/mCB), is greater than 1 then the cell exhibits net growth and if it is less 
than 1 then the bacterium has entered stationary phase. This is recorded with an individual 
based counter, tSP. If R is below 1 during one hour, tSP increases by one. However, a 
(b) 
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bacterium also has the possibility to recover if R increases above 1 before it dies. 
Consequently, if R is above 1 during one hour, tSP decreases by one. As soon as tSP is greater 
than or equal to tSP,limit , the cell dies. 
Bacteria also die if R falls below a certain threshold value. This was done so as to account 
for bacterial death under circumstances of low (or no) nutrient concentration. 
If the biofilm is under antibiotic treatment, then cells die based on certain probability which 
is a function of rate of consumption of antibiotic and bacterial inhibitory concentration, 
which will be seen in section 3.7. 
A cell that is dead no longer consumes nutrient or divides; it neither plays any role in 
quorum sensing nor does it undergo phenotypic switching. Hence, it is removed from the 
simulation domain leaving a free space at its location. 
3.3.4 Detachment  
Dispersal of cells from the biofilm colony is a crucial stage of the biofilm life cycle. It 
enables biofilms to spread and colonize new surfaces, thereby contributing to the 
dissemination of contamination and infection in both clinical and public health settings. 
However, in the current computational model, this process was not considered in detail. 
A cell detaches from the biofilm if it loses contact with the substratum. The contact could be 
direct or indirect (through a cluster of bacteria in which at least one bacterium is directly 
bound to the substratum or via EPS). At the end of each time step, just like in the case of 
bacterial death, detached cells are also removed from the domain & are no longer tracked. 
3.4 Quorum Sensing: Autoinducer Production and Transport 
Every cell in the domain is modeled as being in either up- or down-regulated state. Initially, 
during colonization, all the cells are in the down-regulated state. Cells are allowed to switch 
between the two states, at rates, dependent on the local autoinducer concentration.  
The transition rate from down- to up-regulated state was taken as [64]: 
 
Whereas, the transition rate from up- to down-regulated state was taken as [64]: 
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The probabilities of switching from one state to another within a time interval, Δt, was then 
taken as [64]: 
 
Here, α  is the conversion rate for up-regulation, β is the spontaneous down- regulation rate, 
γ is the transition constant, CA is the local autoinducer concentration, Pu is the probability of 
a cell switching from down- to up-regulated state, Pd is probability of a cell switching from 
up- to down-regulated state. During the simulation, a random number is generated and if the 
probability of switching is greater than the said number, then the cell switches its state. 
Up- and down-regulated cells are assumed to produce and release autoinducer molecules at 
constant rates of rA,u and rA,d, respectively. 
 
Time evolution of autoinducer concentration within the biofilm is given by: 
 
Here, rA is the production rate (molecules/s) of autoinducer molecules, ΔV is the elemental 
volume, CA is the local autoinducer concentration, DA is the diffusivity of autoinducer in the 
biofilm, which is determined by multiplying the diffusion rate in the aqueous phase (DA,aq) 
with the relative effective diffusivity DA,e/DA,aq, v is the local fluid velocity. 
3.5 EPS Production 
Just like the nutrient that had not been consumed for endogenous metabolism was used for 
cell growth at an efficiency YBN, a part of it was also used for production of EPS at an 
efficiency YEN. 
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Here, CE is the local EPS concentration. 
In the current computational model, EPS (if considered), is produced only by up-regulated 
cells. However, if a cell has entered stationary phase (R = rN/mCB < 1), then it doesn’t 
produce any EPS even if it is up-regulated. 
EPS do not grow, die or consume nutrient, but they occupy space and undergo division. 
Once the EPS concentration in a given grid element exceeds the threshold value, it divides 
into two equal parts. One part remains in the original location while the other part moves 
into a neighboring element in the direction that offers least mechanical resistance, just like 
in the case of cell division as was seen in section 3.3.2. In this model, EPS is capable of 
consuming antibiotic. This was an attempt to account for the reaction-diffusion barrier that 
it would offer to the cells in the interior of the biofilm. 
3.6 Phenotypic Switching: HQNO Production and Transport 
In the current computational model, every S. aureus (one of the model bacteria considered) 
cell in the domain is modeled as either wild-type or as an SCV. In fact, SCVs are treated as 
if they were an independent cell species since they are phenotypically different from the 
wild-type. Initially, during colonization, all the S. aureus cells are wild-type only. P. 
aeruginosa (another model bacteria), on the other hand, has only one phenotype i.e. the 
wild-type. 
Down-regulated P. aeruginosa cells were assumed to produce and release HQNO molecules 
at a constant rate of rHQNO,d. However, up-regulated P. aeruginosa cells were assumed to 
produce and release HQNO molecules at a rate rHQNO,u as given below: 
 
Here, YHQNO,N is the efficiency at which a part of the nutrient, that had not been consumed 
for endogenous metabolism, was used for production of HQNO molecules. Note that in the 
case presented here, rHQNO,u, rHQNO,d and YHQNO,N are valid only for P. aeruginosa. 
Time evolution of HQNO concentration within the biofilm is given by: 
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Here, rHQNO (=  rHQNO,u or rHQNO,d) is the production rate of HQNO molecules, CHQNO is the 
local HQNO concentration, DHQNO is the diffusivity of HQNO in the biofilm, which is 
determined by multiplying the diffusion rate in the aqueous phase (DHQNO,aq) with the 
relative effective diffusivity DHQNO,e/DHQNO,aq, v is the local fluid velocity. 
S. aureus cells are allowed to switch between the two phenotypic states, at rates, dependent 
on the local HQNO concentration. 
The transition rate from wild-type to SCV state was taken to be: 
 
whereas, the transition rate from SCV to wild-type state was taken to be: 
 
The probabilities of switching from one phenotypic state to another within a time interval, 
Δt, was then taken to be: 
 
Here, α’ is the conversion rate for SCV-switching, β’ is the spontaneous WT-switching rate, 
γ’ is the transition constant, PSCV is the probability of a cell switching from wild-type (WT) 
to SCV state, PWT is probability of a cell switching from SCV to wild-type (WT) state. 
During the simulation, a random number is generated and if the probability of switching is 
greater than the said number, then the cell switches its phenotypic state. 
3.7 Antimicrobial Drug Administration and Killing 
Antibiotic transport and uptake was modeled within each element of the simulation domain 
by using a discretized form of the three-dimensional convection-diffusion equation: 
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Here, the first clubbed term is the volumetric rate of antibiotic consumption by the cells as 
well as EPS. KB,max is the maximum specific reaction rate of antibiotic with respect to 
biomass (cells) whereas KE,max is the maximum specific reaction rate of antibiotic with 
respect to EPS. KAb is the antibiotic constant (half-saturation coefficient). CAb represents 
antibiotic concentration at each discretized element (x,y,z) and at each time point, t. DAb is 
the diffusivity of antibiotic in the biofilm, which is determined by multiplying the diffusion 
rate in the aqueous phase (DAb,aq) with the relative effective diffusivity DAb,e/DAb,aq, v is the 
local fluid velocity. 
Rate of antibiotic consumption by cells: 
 
Rate of antibiotic consumption by cells at bacterial inhibitory concentration (CBIC): 
 
Maximum antibiotic consumption rate by cells: 
 
The probability of cell death due to antibiotic consumption is given by: 
 
During the simulation, a random number is generated and if the probability of death is 
greater than the said number, then the cell dies. 
3.8 Model Simulation 
The biofilm simulation represents a time march in which the occupancy status of each 
element is updated at every time step. It begins with the creation of the modelling domain 
and establishment of parameter values. At t = 0, a small number (n) of colonizers, were 
randomly placed upon the substratum. The nutrient concentration field was generated by 
obtaining numerical solutions to partial differential equation (3.1) using a finite-difference 
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approach, considering very small time steps. The biomass (bacteria and EPS) was assumed 
to be constant during the transient phase, since the growth of biomass is very slow in 
comparison with nutrient diffusion and consumption [26]. The same approach was used for 
other dissolved entities like autoinducer, HQNO and antibiotic (Eqs. (3.8), (3.11) and (3.15), 
respectively). At each time step, Eqs. (3.3) and (3.9) were solved using the updated nutrient 
concentration field. The bacteria consumed nutrient, and subsequently grew and underwent 
division. If any bacterium satisfied any one of the death rules, then it died. Cells that 
satisfied the detachment requirements were also identified. Both dead and detached cells 
were removed from the domain and no longer tracked. Quorum sensing and phenotypic 
switching were performed based on the local concentrations of autoinducer and HQNO, 
respectively. At the end of each time step, the nutrient reservoir was shifted vertically 
upwards such that a distance of 18 μm from the topmost solid entity (bacterial cell or EPS) 
in the biofilm was always maintained. 
 
Figure 3.3: Sequence of steps during a typical simulation 
21 
 
Table 3.1: Definition of variables and parameters 
Variable/ 
Parameter 
Description Values Unit 
µmax Maximum specific growth rate 
0.3125 (SA), 
0.3125*0.75 (PA), 
0.3125/9 (SA-SCV) 
h-1 
m Maintenance coefficient 0.036 gS gB-1 h-1 
YBN Yield of biomass from nutrient 0.45 gB gS-1 
YEN Yield of EPS from nutrient 0 gEPS gS-1 
YHQNO Yield of HQNO from nutrient 
0 (SA & SA-SCV), 
0.01 (PA) 
gHQNO gS-1 
CN,bulk Bulk nutrient concentration 4 g m-3 
CAb,bulk Bulk antibiotic concentration 7, 9, 11, 13, 15 g m-3 
n No. of colonizers 6 (SA), 6 (PA) Unitless 
Di Diffusivity of component ‘i’ in biofilm  m2 h-1 
Di,aq Diffusion rate of ‘i’ in aqueous phase 
2.52*10-6 (N), 
1.44*10-6 (Ab), 
2.52*10-6 (HQNO), 
1.998*10-6 (aiSA & 
aiPA) 
m2 h-1 
Di,e/Di,aq Relative effective diffusivity 
1/3 (N), 
1/4 (Ab), 
1/3 (HQNO), 
1.5/2 (aiSA), 
1/2 (aiPA) 
Unitless 
Ki Half-saturation coefficient 2.55 (N), 1 (Ab) g m-3 
v Local fluid velocity 0 m h-1 
α Conversion rate for up-regulation (QS) 7.8*10-17 m3 h-1 molecule-1 
β Spontaneous down-regulation rate (QS) 0.975 h-1 
γ Transition constant (QS) 7.9589*10-17 m3 molecule-1 
α' Conversion rate for SCV-switching (PS) 12 m3 h-1 g-1 
β' Spontaneous WT-switching rate (PS) 0 h-1 
γ' Transition constant (PS) 1000 m3 g-1 
rA,u Autoinducer production rate by up-regulated cells 73800 molecules m-3 
rA,d Autoinducer production rate by down-regulated cells 498 molecules m-3 
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rHQNO,u HQNO production rate by up-regulated cells  g m-3 
rHQNO,d HQNO production rate by down-regulated cells 10-8 g m-3 
KB,max 
Maximum specific reaction rate of anitibiotic with 
respect to biomass 
0.5 gAb gB-1 h-1 
KE,max 
Maximum specific reaction rate of anitibiotic with 
respect to EPS 
0.25 gAb gEPS-1 h-1 
mOneCell Mass of one cell 10-12 g 
COneCell Concentration of one cell 37037.037 g m-3 
CBIC Bacterial inhibitory concentration 
0.5 (SA), 
0.25 (PA), 
4*0.5 (SA-SCV) 
g m-3 
Cmax 
Antibiotic concentration corresponding to maximum 
consumption rate 
32 (SA), 
16 (PA), 
4*32 (SA-SCV) 
g m-3 
tSP,limit Stationary phase limit 24 h 
Rthreshold Minimum C to M ratio 0.15 Unitless 
Δt Time step used for CA 1 h 
Δx Element size 3*10-6 m 
Ex No. of elements in x-direction 40 Unitless 
Ez No. of elements in z-direction 40 Unitless 
LMTBL Thickness of MTBL 18*10-6 m 
Ed EPS division threshold concentration 33000 g m-3 
 
* SA = S. aureus, PA = P. aeruginosa, SA-SCV = S. aureus SCV,  
N = Nutrient, Ab = Antibiotic, HQNO = 4-hydroxy-2-heptylquinoline-N-oxide,  
aiSA = Autoinducer of S. aureus, aiPA = Autoinducer of P. aeruginosa
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Chapter 4 
 
Results and Discussion 
   
 
A cellular automata model has been used to investigate the role of presence of small colony 
variants (SCVs) in the antibiotic susceptibility of a mixed-species biofilm comprising of 
Pseudomonas aeruginosa and Staphylococcus aureus. Initially, simulations were run for 
both QS+ (with quorum sensing) and QS- (without quorum sensing) biofilms, at a nutrient 
concentration of 4 g/m3 without any sort of antibiotic treatment and were used as control 
runs. EPS production was kept as zero for all the simulations that were performed. 
Additionally, reversion of SCVs back to WT or WT-like variants were not considered (i.e. 
β’=0). Using the procured control runs, simulations were resumed from a specific time point 
(time at which population of P. aeruginosa attains a maximum value minus 12 hours; differs 
for each control run) following which the biofilm was exposed to antibiotic for 12 
continuous simulation hours. Resumptions were done at different antibiotic concentrations 
of 7, 9, 11, 13 and 15 g/m3. Due to stochastic nature of the model, running multiple 
simulations with the same parameters never really gave identical results but they were 
comparable. Since it is not possible to present all of the simulation results, here we are 
presenting only a few. MATLAB was used as a tool to analyze the data that was obtained 
from the simulations. 
4.1 Antibiotic Concentrations Below the Effective Concentration Prolong 
the Life of a Biofilm 
The polymicrobial biofilm was subjected to a range of antibiotic concentrations varying 
from 7 to 15 g/m3 (Fig. 4.1). At an antibiotic concentration of 13 g/m3, the entire biofilm 
(except S. aureus SCVs) was exterminated within 11 hours of treatment. This specific 
concentration of antibiotic was termed as “effective concentration” and was defined as the 
minimum antibiotic concentration at which wild-type variants of both the species get 
eradicated. Moreover, at an antibiotic concentration of 11 g/m3 (just below the effective 
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concentration), all the wild-type cells couldn’t be obliterated within the 12 hour treatment 
period and the biofilm sustained; therefore this specific concentration of antibiotic was 
termed as “threshold concentration” and was defined as the maximum antibiotic 
concentration which the biofilm (specifically, the wild-type population) can tolerate. 
 
Figure 4.1: Total number of live cells versus time at different antibiotic concentrations; 
Effective antibiotic concentration=13g/m3, Threshold antibiotic concentration=11g/m3 
 
Interestingly, these profiles indicate that using any concentration of antibiotic below the 
effective concentration prolongs the life of the biofilm. 
4.2 Threshold Concentration of Antibiotic Impedes the Transformation of 
Polymicrobial Biofilm Into an Exclusively Mono-Species Biofilm 
S. aureus is much faster growing (greater μmax) and therefore is in direct competition with P. 
aeruginosa for the growth-limiting nutrient and living space. This interaction has key 
implication for the population dynamics and distribution of both the species. Figure 4.2 
illustrates that S. aureus is the dominant species in this polymicrobial biofilm. 
In the absence of antibiotic (control run), the number of P. aeruginosa cells drops down to 
an extent that the entire population transforms into an exclusively mono-species biofilm 
after a certain time point (beyond t = 185h) comprising of only S. aureus species (both wild-
type and SCVs). Thus, S. aureus is able to outcompete P. aeruginosa. 
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Figure 4.2: Number of live cells (species-wise) versus time at threshold antibiotic concentration. 
(a) S. aureus & P. aeruginosa (b) P. aeruginosa & S. aureus SCVs 
 
However, when the biofilm is exposed to antibiotic, the P. aeruginosa subpopulation is able 
to withstand for a longer time. One might assume that this may be because the interspecific 
competition (a form of competition in which members of different species compete for the 
same resource) between the two species is affected. In order to explore this further, spatial 
distribution during the course of antimicrobial treatment, temporal evolution of death 
fractions and effect of concentration of antibiotic on the cell division rate of the two species 
were analyzed. 
Moreover, Fig. 4.2b also manifested the increase in the number of S. aureus SCVs as a 
stress response. 
(a) 
(b) 
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4.3 When the Concentration of Antibiotic is Below the Effective 
Concentration, Dominant Species (S. aureus) Shields the Minor Subpopulation 
(P. aeruginosa) by Hindering Antibiotic Infiltration 
 
 
   
 
       
Figure 4.3: Species-wise fraction of live cells (Number of live cells of a particular species in a 
layer/ Total number of live cells belonging to that species) versus distance from the substratum 
at three different time points: (a) start of antibiotic treatment, t = 93h (b) midway of antibiotic 
treatment, t = 98h (c) end of antibiotic treatment, t = 104h. 
 
Figure 4.3 depicts that at all times, during the course of antibiotic treatment, most of the 
individuals of P. aeruginosa subpopulation are concentrated at the bottom of the biofilm i.e. 
nearer to the substratum (S. aureus partly “blankets” P. aeruginosa; an effect of the 
interspecific competition). At the start of the treatment process, the S. aureus SCVs are 
randomly distributed within the interior of the biofilm and the wild-type S. aureus cells are, 
more or less, evenly distributed across the entire biofilm. However, since the top layers of 
the biofilm are dominated by wild-type variants of S. aureus and the antibiotic starts 
diffusing from the top, it seems reasonable to reckon that they are the ones more prone to 
death. 
(a) t = 93 h (b) t = 98 h (c) t = 104 h 
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27 
 
  
Figure 4.4: (a) Species-wise fraction of dead cells due to antibiotic (Number of dead cells due to 
antibiotic of a particular species/Total number of live and dead cells of that species) versus 
time. Species-wise fraction of live and dead cells (Number of live (or dead due to antibiotic) 
cells of a particular species in a layer/Total number of live and dead cells of the same species in 
the same layer) versus distance from substratum at (b) t = 93h (c) t = 103h. 
 
With the commencement of antimicrobial dosing, wild-type S. aureus variants were most 
afflicted (Fig. 4.4) as was anticipated based on the spatial distribution of the two species. In 
the early stages of the treatment, S. aureus (WT) hindered the diffusion of antibiotic into the 
depths of the biofilm by consuming it; thereby shielding P. aeruginosa from the direct 
action of the antimicrobial agent to a certain extent. However, after a while, the viability of 
P. aeruginosa decreased sharply as the permeation of the antibiotic outpaced the 
“neutralization” by S. aureus (WT).  
(a) 
(b) t = 93h (c) t = 103h 
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0                 3                   6                    9                  12                 15                 18                 21 
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Subsequently, the impact of concentration of antibiotic on the proliferation of the two 
species was investigated (Fig. 4.5). 
 
 
Figure 4.5: (a) Cell division rate (ratio of number of mother cells to number of live cells/delta t) 
versus antibiotic concentration during the antibiotic treatment period for wild-type S. aureus 
and wild-type P. aeruginosa. (b) Average concentration of nutrient at the substratum versus 
concentration of antibiotic. 
 
Rate of cell division of S. aureus (WT) species decreases with increasing concentration of 
antibiotic. In other words, cell death of S. aureus wild-type variants has overwhelmed their 
cell division and the effect enhances with increasing antibiotic concentration.  
In the absence of antibiotic, the dominating wild-type variants of S. aureus deprived the P. 
aeruginosa species from growing up to its full potential by depriving it of the growth-
limiting nutrient. On the other hand, in presence of antibiotic, as the cell count of S. aureus 
7 9 11 13 
(a) 
(b) 
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(WT) declines, the biofilm loses its compact structure and becomes porous. Subsequently, 
nutrient diffuses more effectively into the deeper layers of the biofilm (Fig. 4.5b). As a 
result, P. aeruginosa at the bottom gains ample access to the common nutrient and is able to 
thrive (up to the threshold antibiotic concentration). But beyond the threshold antibiotic 
concentration, cell death rate of P. aeruginosa overpowers the cell division rate. 
It was discerned in section 4.2 that at threshold antibiotic concentration S. aureus SCVs also 
increased as a stress response along with the P. aeruginosa subpopulation. And here it was 
observed that increasing antibiotic concentration (up to the threshold antibiotic 
concentration) favors P. aeruginosa. Thus, in order to inspect whether S. aureus SCVs 
followed a similar trend, fractions of SCVs were plotted against time at different antibiotic 
concentrations. 
4.4 Production of SCVs is Potentiated in Response to Antibiotic Treatment, 
Indicating That SCV Production Acts as a Defense Mechanism Against 
External Stresses 
For the control run (without antibiotic treatment), the S. aureus SCV fraction diminishes 
with time (Fig. 4.6). This is because, in the absence of any antimicrobial agent, the wild-
type cells proliferate when compared to SCVs which are slow-growing; the SCVs are 
unable to compete with the wild-type cells for the common nutrient and as a consequence 
get killed. On the other hand, in the presence of antibiotic, nutrient diffusion into the biofilm 
increases as time progresses (Fig. 4.5b) and the SCVs gain more access to it, just like in the 
case of P. aeruginosa species. 
 
Figure 4.6: Fraction of S. aureus SCVs versus time at different antibiotic concentrations 
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As the P. aeruginosa subpopulation is being shielded by the wild-type variants of S. aureus 
and its cell division rate increases with increasing antibiotic concentration (observed in 
section 4.3), it continues to produce HQNO, in turn improving the probability of phenotypic 
switching which is dependent on the local HQNO concentration. Consequently, the fraction 
of SCVs increases with the concentration of antibiotic (Fig. 4.6).  
 
Figure 4.7: Number of dead S. aureus SCVs versus antibiotic concentration 
 
Additionally, Fig. 4.7 depicts that SCV-death is lesser in the presence of antibiotic (up to 
threshold antibiotic concentration) as compared to that in the absence of antibiotic (control 
run). Hence, in simple words, it can be said that SCV production is potentiated only when a 
defense mechanism is required. 
As the antimicrobial treatment starts, bacteria are killed first near the biofilm-bulk fluid 
interface. With time, the killing front (defined as the location in the biofilm where the live 
and dead cell concentrations are equal) progresses inward towards the substratum (Fig. 
4.8a). The killing front divides the entire biofilm into two zones: above the killing front, 
effect of antibiotic is more pronounced whereas below the killing front, cells that survive are 
more in number compared to those that die. 
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Figure 4.8: Fraction of live and dead (antibiotic) cells versus distance from substratum, (a) in 
the absence of SCVs, antibiotic treatment from 99 to 110h; (b)-(d) in the presence of SCVs, 
antibiotic treatment from 93 to 104h 
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In the presence of SCVs, similar trend was observed for the first few hours (up to 7 hours) 
of antibiotic treatment (Fig. 4.8b), following which the biofilm was stratified into three 
zones: (i) below killing front, (ii) above killing front but below survival front, and (iii) 
above survival front; as opposed to just two in the case with the absence of SCVs. The 
survival front is characterized by an SCV-dominated zone above it and is the location from 
where biphasic patterns were encountered (Fig. 4.8c&d). This was because the SCVs that 
were earlier present within the interior of the biofilm got exposed at the top as the cells 
above them got killed (Fig. 4.9) and since the SCVs are refractory (higher BIC than wild-
type), they don’t die immediately. 
     
 
 
Figure 4.9: 2-D Visualization of live cells [S. aureus-WT (green), P. aeruginosa-WT (blue), S. 
aureus-SCV (pink)] at (a) 93h, (b) 102h. The isolines indicate the nutrient concentration 
distribution across the domain. Species-wise fraction of live cells versus distance from 
substratum at (c) 93h, (d) 102h. 
 
In the absence of SCVs, killing front moves at a velocity of approximately 1.8 µm h-1 
whereas when the SCVs are present, the velocity is 2.275 µm h-1. The rate at which the 
killing front advances appears to be determined by the rate at which the antibiotic penetrates 
into the biofilm (Fig. 4.10); hence this is purely a physical phenomenon. Thus, SCV 
production retards antibiotic infiltration to some extent.  
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Figure 4.10: Average antibiotic concentration versus distance from the substratum at the start 
and end of antibiotic treatment for two cases: in the presence and absence of S. aureus SCVs 
As a result, even after 12 hours of antimicrobial treatment, the death fraction at the bottom 
of the substratum is lower in the presence of SCVs (12.5%, Fig. 4.8b) when compared to the 
biofilm without SCVs (40%, Fig. 4.8a). 
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Chapter 5 
 
Conclusion  
   
 
A 3-D cellular automata computational model was developed as a tool to investigate the role 
of small colony variants (SCVs) in the antibiotic susceptibility of polymicrobial biofilms. In 
general, this model could be utilized for any bacterial population that switches between two 
different growth phenotypes in response to a molecular signal. 
Our investigation revealed that treating a biofilm with antibiotic concentration less than the 
effective concentration allows the biofilm to regrow and therefore prolongs its lifetime. 
Interspecific competition plays a significant role in the population dynamics and distribution 
of species within the biofilm community. For example, faster growing species divest others 
from growing up to their full potential by depriving them of the growth-limiting nutrient. 
However, external stress can influence the interspecific competition; for instance, faster 
growing cells which would have been the dominant species within the biofilm, die faster in 
the presence of antibiotic. When treated with antibiotic, if the concentration of antibiotic is 
below the effective concentration, dominant species (S. aureus) shields the minor 
subpopulation (P. aeruginosa) by hindering antibiotic infiltration up to a certain extent. An 
added effect to this is improved diffusion of nutrient into the depths of the biofilm enabling 
the minor subpopulation to grow effectively. However, beyond the threshold antibiotic 
concentration, cell death rate overpowers cell division rate. Production of SCVs is 
potentiated in response to antibiotic treatment, indicating that SCV production acts as a 
defense mechanism against external stresses. The SCVs retard antibiotic permeation due to 
their refractory nature (higher BICs). As a result, even after using same antimicrobial 
treatment, the fraction of dead cells at the bottom of the substratum is lower in the presence 
of SCVs than when compared to a biofilm without SCVs. Thus our simulations collectively 
demonstrate that presence of SCVs within a biofilm is a plausible mechanism for the 
antibiotic tolerance of mixed-species biofilms. 
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Chapter 6 
 
Future Work  
   
 
Stewart et al. (2005) demonstrate that splitting of bacteria is functionally asymmetric, even 
in symmetric dividers [65]. Upon division, one progeny inherits the effects of age while the 
other does not. The hypothesis is that older cells are more tolerant than younger cells to 
antimicrobial challenge [66]. Thus age structure could be incorporated in the model to test 
the persistence of biofilms due to senescence. 
Another focus of research could be to study the influence of biofilm morphology on 
antibiotic tolerance. It would involve commencing simulations with pre-determined 
morphologies- varied shapes, porosities, diffusion distances etc., followed by subjecting the 
biofilm to external stresses like antimicrobial treatment. The role of different spatial 
distributions (separate microcolonies, coaggregation or layering) could also be analyzed. 
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